Viewing Study NCT04987320


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-03-04 @ 11:11 PM
Study NCT ID: NCT04987320
Status: COMPLETED
Last Update Posted: 2025-02-10
First Post: 2021-07-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Olpasiran in Chinese Participants With Elevated Serum Lipoprotein(a)
Sponsor: Amgen
Organization: